Respiratory and hemodynamic effects of 2 protocols of low-dose infusion of dexmedetomidine in dogs under isoflurane anesthesia

Caterina Di Bella, Despoina Skouropoulou, Marzia Stabile, Cosmin Muresan, Salvatore Grasso, Luca Lacitignola, Luisa Valentini, Antonio Crovace, Francesco Staffieri, Caterina Di Bella, Despoina Skouropoulou, Marzia Stabile, Cosmin Muresan, Salvatore Grasso, Luca Lacitignola, Luisa Valentini, Antonio Crovace, Francesco Staffieri

Abstract

The aim of this study was to evaluate the respiratory and hemodynamic effects of a low-dose dexmedetomidine infusion [1 μg/kg body weight (BW) per hour], with or without a loading dose (1 μg/kg BW), in dogs under isoflurane anesthesia. Thirty dogs were premedicated with methadone [0.3 mg/kg BW intramuscular (IM)], induced with propofol intravenous (IV) and maintained with isoflurane (1.3% to 1.4%) under mechanical ventilation. Animals were randomly assigned to 3 intravenous (IV) treatments (n = 10): 1 μg/kg BW dexmedetomidine, followed by 1 μg/kg BW per hour (group BI); or saline solution bolus, followed by either an infusion of 1 μg/kg BW per hour dexmedetomidine (group I) or saline solution (group C). The infusions were interrupted after 30 minutes. Respiratory system static compliance (Cstat) and respiratory system resistance (Rrs), partial pressure of oxygen/fractional inspired oxygen ratio (PaO2/FIO2), intrapulmonary shunt (Fshunt), and cardiac output (CO) were determined 5 minutes before the bolus (BASELINE), at the end of the bolus (BOLUS), and at 15 (T15), 30 (T30), and 45 minutes (T45) intervals. In group BI, Cstat and PaO2/FiO2 were higher at T15 and T30 than at BASELINE in the same group and than group C at the same times. In group I, the same parameters at T30 were higher than at BASELINE and than group C at the same time. In group BI, Rrs and Fshunt were lower than at BASELINE and than group C at the same time. In group I, the same parameters at T30 were lower than at BASELINE and those of group C at the same time. Cardiac output (CO) at T30 was higher in groups BI and I than in group C. The results of this study showed that low-dose dexmedetomidine infusion improves oxygenation and respiratory system mechanics and has a stabilizing hemodynamic effect in dogs anesthetized with isoflurane and mechanically ventilated.

Conflict of interest statement

Conflict of interest statement The authors do not have any conflict of interest to declare.

Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Figures

Figure 1
Figure 1
Mean ± SD values of respiratory system static compliance (Cstat, mL/cmH2O/kg) in 30 dogs undergoing ovariectomy under isoflurane general anesthesia. In group BI (n = 10, solid line), dogs received a bolus [1 μg/kg body weight (BW) per hour, IV], followed by a continuous rate infusion (CRI) of dexmedetomidine (1 μg/kg BW per hour, IV). In group I (n = 10, dashed line), dogs received a bolus of Ringer’s lactate solution IV, followed by a CRI of dexmedetomidine (1 μg/kg BW per hour, IV). In group C (n = 10, dotted line), dogs received a bolus and a CRI of Ringer’s lactate solution IV. The drug infusion started after the induction and was interrupted 30 min later (T30). The data were registered before the beginning of the infusion (BASELINE), at the end of bolus (BOLUS), and at 15 (T15), 30 (T30), and 45 (T45) min after the beginning of the infusion. * P < 0.05 compared to group C at the same study time; #P < 0.05 compared to group I at the same study time; aP < 0.05 compared to BASELINE in the same group.
Figure 2
Figure 2
Mean ± SD values of total resistance of the respiratory system (Rrs, cmH2O/L/s) in 30 dogs undergoing ovariectomy under isoflurane general anesthesia. In group BI (n = 10, solid line), dogs received a bolus [1 μg/kg body weight (BW,) IV], followed by a continuous rate infusion (CRI) of dexmedetomidine (1 μg/kg BW per hour, IV). In group I (n = 10, dashed line), dogs received a bolus of Ringer’s lactate solution IV, followed by a CRI of dexmedetomidine (1 μg/kg BW per hour, IV). In group C (n = 10, dotted line), dogs received a bolus and a CRI of Ringer’s lactate solution IV. The drug infusion started after the induction and was interrupted 30 min later (T30). The data were registered before the beginning of the infusion (BASELINE), at the end of bolus (BOLUS), and at 15 (T15), 30 (T30), and 45 (T45) min after the beginning of the infusion. * P < 0.05 compared to group C at the same study time; aP < 0.05 compared to BASELINE in the same group.
Figure 3
Figure 3
Mean ± SD values of arterial oxygen partial pressure/fractional inspired oxygen ratio (PaO2/FiO2) in 30 dogs undergoing ovariectomy under isoflurane general anesthesia. In group BI (n = 10, solid line), dogs received a bolus [1 μg/kg body weight (BW), IV], followed by a continuous rate infusion (CRI) of dexmedetomidine (1 μg/kg BW per hour, IV). In group I (n = 10, dashed line), dogs received a bolus of Ringer’s lactate solution IV, followed by a CRI of dexmedetomidine (1 μg/kg BW per hour, IV). In group C (n = 10, dotted line), dogs received a bolus and a CRI of Ringer’s lactate solution IV. The drug infusion started after the induction and was interrupted 30 min later (T30). The data were registered before the beginning of the infusion (BASELINE), at the end of bolus (BOLUS), and at 15 (T15), 30 (T30), and 45 (T45) min after the beginning of the infusion. * P < 0.05 compared to group C at the same study time; #P < 0.05 compared to group I at the same study time; aP < 0.05 compared to BASELINE in the same group.
Figure 4
Figure 4
Mean ± SD values of estimated intrapulmonary shunt (Fshunt) in 30 dogs undergoing ovariectomy under isoflurane general anesthesia. In group BI (n = 10, solid line), dogs received a bolus [1 μg/kg body weight (BW), IV], followed by a continuous rate infusion (CRI) of dexmedetomidine (1 μg/kg BW per hour, IV). In group I (n = 10, dashed line), dogs received a bolus of Ringer’s lactate solution IV, followed by a CRI of dexmedetomidine (1 μg/kg BW per hour, IV). In group C (n = 10, dotted line), dogs received a bolus and a CRI of Ringer’s lactate solution IV. The drug infusion started after the induction and was interrupted 30 min later (T30). The data were registered before the beginning of the infusion (BASELINE), at the end of bolus (BOLUS), and at 15 (T15), 30 (T30), and 45 (T45) min after the beginning of the infusion. * P < 0.05 compared to group C at the same study time; #P < 0.05 compared to group I at the same study time; aP < 0.05 compared to BASELINE in the same group.
Figure 5
Figure 5
Mean ± SD values of cardiac index (CI) in 30 dogs undergoing ovariectomy under isoflurane general anesthesia. In group BI (n = 10, solid line), dogs received a bolus [1 μg/kg body weight (BW), IV], followed by a continuous rate infusion (CRI) of dexmedetomidine (1 μg/kg BW per hour, IV). In group I (n = 10, dashed line), dogs received a bolus of Ringer’s lactate solution IV, followed by a CRI of dexmedetomidine (1 μg/kg BW per hour, IV). In group C (n = 10, dotted line), dogs received a bolus and a CRI of Ringer’s lactate solution IV. The drug infusion started after the induction and was interrupted 30 min later (T30). The data were registered before the beginning of the infusion (BASELINE), at the end of bolus (BOLUS), and at 15 (T15), 30 (T30), and 45 (T45) min after the beginning of the infusion. * P < 0.05 compared to group C at the same study time; aP < 0.05 compared to BASELINE in the same group; bP < 0.05 compared to BOLUS in the same group.

References

    1. Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: A novel sedative-analgesic agent. Proc (Bayl Univ Med Cent) 2001;14:13–21.
    1. Chabot-Doré AJ, Schuster DJ, Stone LS, Wilcox GL. Analgesic synergy between opioid and alpha-2-adrenoceptors. Br J Pharmacol. 2015;172:388–402.
    1. Clarke KW, Hall LW. “Xylazine” — A new sedative for horses and cattle. Vet Rec. 1969;85:512–517.
    1. Lemke KA. Perioperative use of selective alpha-2 agonists and antagonists in small animals. Can Vet J. 2004;45:475–480.
    1. Alvaides RK, Neto FJ, Aguiar AJ, Campagnol D, Steagall PV. Sedative and cardiorespiratory effects of acepromazine or atropine given before dexmedetomidine in dogs. Vet Rec. 2008;162:852–856.
    1. Rankin DC. Sedatives and tranquilizers. In: Grimm KA, Lamont LA, Tranquilli WJ, Green SA, Robertson SA, editors. Veterinary Anesthesia and Analgesia. 5th ed. Ames, Iowa: Wiley & Sons; 2015. pp. 196–206.
    1. Kuusela E, Raekallio M, Vaisanen M, Mykkanen K, Ropponen H, Vainio O. Comparison of medetomidine and dexmedetomidine as premedicants in dogs undergoing propofol-isoflurane anesthesia. Am J Vet Res. 2001;62:1073–1080.
    1. Nishimura LT, Auckburally A, Santilli J, et al. Effects of dexmedetomidine combined with commonly administered opioids on clinical variables in dogs. Am J Vet Res. 2018;79:267–275.
    1. Kuusela E, Vainio O, Short CE, et al. A comparison of propofol infusion and propofol/isoflurane anaesthesia in dexmedetomidine premedicated dogs. J Vet Pharmacol Ther. 2003;26:199–204.
    1. Murrell JC, Hellebrekers LJ. Medetomidine and dexmedetomidine: A review of cardiovascular effects and antinociceptive properties in the dog. Vet Anaesth Analg. 2005;32:117–127.
    1. Bloor BC, Frankland M, Alper G, Raybould D, Weitz J, Shurtliff M. Hemodynamic and sedative effects of dexmedetomidine in dog. J Pharmacol Exp Ther. 1992;263:690–697.
    1. Congdon JM, Marquez M, Niyom S, Boscan P. Cardiovascular, respiratory, electrolyte and acid-base balance during continuous dexmedetomidine infusion in anesthetized dogs. Vet Anaesth Analg. 2013;40:464–471.
    1. Lerche P, Muir WW., 3rd Effect of medetomidine on breathing and inspiratory neuromuscular drive in conscious dogs. Am J Vet Res. 2004;65:720–724.
    1. Nguyen D, Abdul-Rasool I, Ward D, et al. Ventilatory effects of dexmedetomidine, atipamezole, and isoflurane in dogs. Anesthesiology. 1992;76:573–579.
    1. Ko JC, Barletta M, Sen I, et al. Influence of ketamine on the cardiopulmonary effects of intramuscular administration of dexmedetomidine-buprenorphine with subsequent reversal with atipamezole in dogs. J Am Vet Med Assoc. 2013;242:339–345.
    1. Kelman GR, Nunn JF, Prys-Roberts C, Greenbaum R. The influence of cardiac output on arterial oxygenation: A theoretical study. Br J Anaesth. 1967;39:450–458.
    1. Wijeysundera DN, Bender JS, Beattie WS. Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database Syst Rev. 2009:CD004126.
    1. Kabukçu HK, Sahin N, Temel Y, Titiz TA. Hemodynamics in coronary artery bypass surgery: Effects of intraoperative dexmedetomidine administration. Anaesthesist. 2011;60:427–431.
    1. Pascoe PJ. The cardiopulmonary effects of dexmedetomidine infusions in dogs during isoflurane anesthesia. Vet Anaesth Analg. 2015;42:360–368.
    1. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125–1133.
    1. Xia R, Yin H, Xia ZY, Mao QJ, Chen GD, Xu W. Effect of intravenous infusion of dexmedetomidine combined with inhalation of isoflurane on arterial oxygenation and intrapulmonary shunt during single-lung ventilation. Cell Biochem Biophys. 2013;67:1547–1550.
    1. Lee SH, Kim N, Lee CY, Ban MG, Oh YJ. Effects of dexmedetomidine on oxygenation and lung mechanics in patients with moderate chronic obstructive pulmonary disease undergoing lung cancer surgery: A randomised double-blinded trial. Eur J Anaesthesiol. 2016;33:275–282.
    1. Hasanin A, Taha K, Abdelhamid B, et al. Evaluation of the effects of dexmedetomidine infusion on oxygenation and lung mechanics in morbidly obese patients with restrictive lung disease. BMC Anesthesiol. 2018;18:104.
    1. Lin GY, Robben JH, Murrell JC, Aspegrén J, McKusick BC, Hellebrekers LJ. Dexmedetomidine constant rate infusion for 24 hours during and after propofol or isoflurane anaesthesia in dogs. Vet Anaesth Analg. 2008;35:141–153.
    1. Pascoe PJ, Raekallio M, Kuusela E, McKusick B, Granholm M. Changes in the minimum alveolar concentration of isoflurane and some cardiopulmonary measurements during three continuous infusion rates of dexmedetomidine in dogs. Vet Anaesth Analg. 2006;33:97–103.
    1. Uilenreef JJ, Murrell JC, McKusick BC, Hellebrekers LJ. Dexmedetomidine continuous rate infusion during isoflurane anaesthesia in canine surgical patients. Vet Anaesth Analg. 2008;35:1–12.
    1. Gottfried SB, Higgs BD, Rossi A, et al. Interrupter technique for measurement of respiratory mechanics in anesthetized humans. J Appl Physiol. 1985;59:647–652.
    1. De Monte V, Grasso S, De Marzo C, Crovace A, Staffieri F. Effects of reduction of inspired oxygen fraction or application of positive end-expiratory pressure after an alveolar recruitment maneuver on respiratory mechanics, gas exchange, and lung aeration in dogs during anesthesia and neuromuscular blockade. Am J Vet Res. 2013;74:25–33.
    1. Araos JD, Larenza MP, Boston RC, et al. Use of the oxygen content-based index, Fshunt, as an indicator of pulmonary venous admixture at various inspired oxygen fractions in anesthetized sheep. Am J Vet Res. 2012;73:2013–2020.
    1. Briganti A, Evangelista F, Centonze P, et al. A preliminary study evaluating cardiac output measurement using Pressure Recording Analytical Method (PRAM) in anaesthetized dogs. BMC Vet Res. 2018;14:72.
    1. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149–1160.
    1. Hedenstierna G, Edmark L. Effects of anesthesia on the respiratory system. Best Pract Res Clin Anaesthesiol. 2015;29:273–284.
    1. McDonell WN, Kerr CL. Physiology, pathophysiology, and anesthetic management of patients with respiratory disease. In: Grimm KA, Lamont LA, Tranquilli WJ, Greene SA, Robertson SA, editors. Veterinary Anesthesia and Analgesia. 5th ed. Ames, Iowa: Wiley & Sons; 2015. pp. 513–555.
    1. De Monte V, Bufalari A, Grasso S, et al. Respiratory effects of low versus high tidal volume with or without positive end-expiratory pressure in anesthetized dogs with healthy lungs. Am J Vet Res. 2018;79:496–504.
    1. Haskins S, Pascoe PJ, Ilkiw JE, Fudge J, Hopper K, Aldrich J. Reference cardiopulmonary values in normal dogs. Comp Med. 2005;55:156–161.
    1. Buget MI, Sungur Z, Ozkan B, Yornuk M, Demircan F, Senturk M. The effect of dexmedetomidine on oxygenation and intrapulmonary shunt during one lung ventilation. Open J Anesthesiol. 2015;5:135–141.
    1. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4:302–308.
    1. Groeben H, Mitzner W, Brown RH. Effects of the alpha2-adrenoceptor agonist dexmedetomidine on bronchoconstriction in dogs. Anesthesiology. 2004;100:359–363.
    1. Grundström N, Andersson RG, Wikberg JE. Prejunctional alpha 2 adrenoceptors inhibit contraction of tracheal smooth muscle by inhibiting cholinergic neurotransmission. Life Sci. 1981;28:2981–2986.
    1. Kernan S, Rehman S, Meyer T, Bourbeau J, Caron N, Tobias JD. Effects of dexmedetomidine on oxygenation during one-lung ventilation for thoracic surgery in adults. J Minim Access Surg. 2011;7:227–231.
    1. Honkavaara JM, Restitutti F, Raekallio MR, Kuusela EK, Vainio OM. The effects of increasing doses of MK-467, a peripheral alpha(2)-adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs. J Vet Pharmacol Ther. 2011;34:332–337.
    1. Grasso SC, Ko JC, Weil AB, Paranjape V, Constable PD. Hemodynamic influence of acepromazine or dexmedetomidine premedication in isoflurane-anesthetized dogs. J Am Vet Med Assoc. 2015;246:754–764.
    1. Kersten J, Pagel PS, Tessmer JP, Roerig DL, Schmeling WT, Warltier DC. Dexmedetomidine alters the hemodynamic effects of desflurane and isoflurane in chronically instrumented dogs. Anesthesiology. 1993;79:1022–1032.
    1. Quirós Carmona S, Navarrete-Calvo R, Granados MM, et al. Cardiorespiratory and anaesthetic effects of two continuous rate infusions of dexmedetomidine in alfaxalone anaesthetized dogs. Res Vet Sci. 2014;97:132–139.

Source: PubMed

3
Abonnieren